Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;298(Pt A):364-372.
doi: 10.1016/j.jad.2021.10.115. Epub 2021 Nov 3.

Prevalence rates of anxiety, depressive, and eating pathology symptoms between the pre- and peri-COVID-19 eras: A meta-analysis

Affiliations
Review

Prevalence rates of anxiety, depressive, and eating pathology symptoms between the pre- and peri-COVID-19 eras: A meta-analysis

Katherine Musacchio Schafer et al. J Affect Disord. .

Abstract

COVID-19 emerged in 2019 and has since killed more than two and a half million people worldwide. Several studies have investigated the role of COVID-19 on the prevalence of mental health outcomes, with general findings indicating elevated rates of mental health issues as compared to the pre-COVID-19 era. However, the effect of specific demographic features is less clear. As such, we investigated whether anxiety, depressive, and eating pathology symptoms varied by gender, age, status as a medical provider (compared to the general public), race, or region of origin. Forty-three effect sizes from 36 studies indicated that all three symptoms increased from pre- to peri‑COVID-19-eras across all regions. No symptom varied by age, status as a medical provider, or race, though females were significantly more likely to experience eating pathology than males. Findings from our study indicate that worldwide, regardless of age, status as a medical provider, race, or region of origin, respondents experienced significantly elevated rates of psychopathology symptoms during the onset of the COVID-19 pandemic.

Keywords: Anxiety; COVID-19; Depression; Eating pathology; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to disclose.

Figures

Fig 1
Fig. 1
PRISMA Reporting of papers and effect sizes included in the present study.
Fig 2
Fig. 2
Prevalence rates of anxiety, depressive, and eating pathology symptoms prior to and during COVID-19 pandemic.
Fig 3
Fig. 3
Funnel plots for evidence of missing studies regarding prevalence rates of psychopathology during COVID-19.

References

    1. Baxter A.J., Scott K.M., Vos T., Whiteford H.A. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol. Med. 2013;43(5):897. - PubMed
    1. Boldrini T., Girardi P., Clerici M., Conca A., Creati C., Di Cicilia G., Lomoriello A.S. Consequences of the COVID-19 pandemic on admissions to general hospital psychiatric wards in Italy: reduced psychiatric hospitalizations and increased suicidality. Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2021;110 - PMC - PubMed
    1. Capraro, V., & Barcelo, H. (2020, May 11). The effect of messaging and gender on intentions to wear a face covering to slow down COVID-19 transmission., 10.31234/osf.io/tg7vz. - DOI - PMC - PubMed
    1. Ciccone M.M., Aquilino A., Cortese F., Scicchitano P., Sassara M., Mola E., Bux F. Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo) Vasc. Health Risk Manag. 2010;6:297. - PMC - PubMed
    1. Eisenberg D., Nicklett E.J., Roeder K., Kirz N.E. Eating disorder symptoms among college students: prevalence, persistence, correlates, and treatment-seeking. J. Am. Coll. Health. 2011;59(8):700–707. - PMC - PubMed